Sulfonylurea stimulation of insulin secretion

Diabetes

Volumn 51, Issue SUPPL. 3, 2002, Pages

  Proks, Peter ^a   Reimann, Frank ^b   Green, Nick ^a   Gribble, Fiona ^b   Ashcroft, Frances ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; GLIBENCLAMIDE; GLICLAZIDE; GLIMEPIRIDE; GLIPIZIDE; MAGNESIUM; MEGLITINIDE; NATEGLINIDE; POTASSIUM CHANNEL; RECEPTOR SUBUNIT; REPAGLINIDE; SULFONYLUREA; SULFONYLUREA RECEPTOR; TOLBUTAMIDE; TRIPHOSPHOINOSITIDE;

CHANNEL GATING; CONFERENCE PAPER; CONTROLLED STUDY; DRUG BINDING; DRUG BINDING SITE; DRUG EFFECT; DRUG EFFICACY; DRUG SENSITIVITY; HEART MUSCLE; HUMAN; INSULIN RELEASE; KINETICS; MATHEMATICAL COMPUTING; MUTATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; SKELETAL MUSCLE; SMOOTH MUSCLE;

EID: 0036894342     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.2007.s368     Document Type: Conference Paper

References (55)

1. Ashcroft FM, Rorsman P: Electrophysiology of the pancreatic beta-cell. Prog Biophys Mol Biol 54:87-143, 1989
2. Nichols CG, Lederer WJ: Adenosine triphosphate-sensitive potassium channels in the cardiovascular system. Am J Physiol 261:H1675-H1686, 1991
3. + channels in the hypothalamus are essential for the maintenance of glucose homeostasis. Nat Neurosci 4:507-512, 2001
4. Yamada K, Ji JJ, Yuan H, Miki T, Sato S, Horimoto N, Shimizu T, Seino S, Inagaki N: Protective role of ATP-sensitive potassium channels in hypoxia-induced generalized seizure. Science 292:1543-1546, 2001
5. Quayle JM, Nelson MT Standen NB: ATP-sensitive and inwardly rectifying potassium channels in smooth muscle. Physiol Rev 77:1165-1232, 1997
6. + channels and insulin secretion: Their role in health and disease. Diabetologia 42:903-919, 1999
7. Aguilar-Bryan L, Bryan J: Molecular biology of adenosine triphosphate-sensitive potassium channels. Endocr Rev 20:101-135, 1999
8. Tucker SJ, Gribble FM, Zhao C, Trapp S, Ashcroft FM: Truncation of Kir6.2 produces ATP-sensitive K-channels in the absence of the sulphonylurea receptor. Nature 387:179-181, 1997
9. Nichols CG, Shyng SL, Nestorowicz A, Glaser B, Clement JP, Gonzalez G, Aguilar-Bryan L, Permutt MA, Bryan J: Adenosine diphosphate as an intracellular regulator of insulin secretion. Science 272:1785-1787, 1996
10. ATP channel by interaction with its SUR1 subunit. Proc Natl Acad Sci U S A 95:7185-7190, 1998
11. Gribble FM, Tucker SJ, Ashcroft FM: The essential role of the Walker A motifs of SUR1 in K-ATP channel activation by Mg-ADP and diazoxide. EMBO J 16:1145-1152, 1997
12. ATP channel activity by diazoxide and MgADP: Distinct functions of the two nucleotide binding folds of the sulfonylurea receptor. J Gen Physiol 110:643-654, 1997
13. Aguilar-Bryan L, Nichols CG, Wechsler SW, Clement JP 4th, Boyd AE 3rd, Gonzalez G, Herrera-Sosa H, Nguy K, Bryan J, Nelson DA: Cloning of the beta-cell high-affinity sulphonylurea receptor: A regulator of insulin secretion. Science 268:423-425, 1995
14. + channels. Neuron 16:1011-1017, 1996
15. + channel. J Biol Chem 271:24321-24325, 1996
16. Mukai E, Ishida H, Horie M, Noma A, Seino Y, Takano M: The antiarrhythmic agent cibenzoline inhibits K-ATP channels by binding to Kir6.2. Biochem Biophys Res Commun 251:477-481, 1998
17. Proks P, Ashcroft FM: Phentolamine block of K-ATP channels is mediated by Kir6.2. Proc Natl Acad Sci U S A 94:11716-11720, 1997
18. Gribble FM, Davis TME, Higham CE, Clark A, Ashcroft FM: The antimalarial agent mefloquine inhibits ATP-sensitive K-channels. Br J Pharmacol 131:756-760, 2000
19. ATP channels to gliclazide. Diabetologia 42:845-848, 1999
20. Gribble FM, Tucker SJ, Ashcroft FM: The interaction of nucleotides with the tolbutamide block of K-ATP currents: A reinterpretation. J Physiol 504:35-45, 1997
21. ATP channels. Diabetes 47:1412-1418, 1998
22. Dörschner H, Brekardin E, Uhde I, Schwanstecher C, Schwanstecher M: Stoichiometry of sulfonylurea-induced ATP-sensitive potassium channel closure. Mol Pharmacol 55:1060-1066, 1999
23. + channel Kir6.1 increases the affinity of the vascular sulfonylurea receptor SUR2B for glibenclamide. Mol Pharmacol 56:955-961, 1999
24. ATP channels of mammalian skeletal muscle. J Membr Biol 155:257-262, 1997
25. Reimann F, Tucker SJ, Proks P, Ashcroft FM: Involvement of the N-terminus of Kir6.2 in coupling to the sulphonylurea receptor. J Physiol 518:325-336, 1999
26. ATP channel conferred by a novel splice variant of SUR1. J Physiol 521:337-350, 1999
27. Trapp S, Proks P, Tucker SJ, Ashcroft FM: Molecular analysis of ATP-sensitive K channel gating and implications for channel inhibition by ATP. J Gen Physiol 112:333-349, 1998
28. ATP channels: Functional coupling of Kir6.2 and SUR1 subunits. J Gen Physiol 114:203-213, 1999
29. + channel openers, and ATP. Mol Pharmacol 59:1086-1093, 2001
30. ATP channels. Science 282:1139-1141, 1998
31. ATP channels. Science 282:1141-1144, 1998
32. + channels and insulin secretion: Comparison with the sulfonylureas and nateglinide. Eur J Pharmacol 431:119-125, 2001
33. Reimann F, Proks P, Ashcroft FM: Effects of mitiglinide (S 21403) on Kir6.2/SUR1, Kir6.2/SUR2A and Kir6.2/SUR2B types of ATP-sensitive potassium channel. Br J Pharmacol 132:1542-1548, 2001
34. Song DK, Ashcroft FM: Glimepiride block of cloned β-cell, cardiac and smooth muscle K-ATP channels. Br J Pharmacol 133:193-199, 2001
35. ATP channel. Diabetes 48:1341-1347, 1999
36. Hambrock A, Löffler-Walz C, Russ U, Lange U, Quast U: Characterization of a mutant sulfonylurea receptor SUR2B with high affinity for sulfonylureas and openers: Differences in the coupling to Kir6.x subtypes. Mol Pharmacol 60:190-199, 2001
37. Löffler-Walz C, Hambrock A, Quast U: Interaction of K-ATP channel modulators with sulfonylurea receptor SUR2B: Implication for tetramer formation and allosteric coupling of subunits. Mol Pharmacol 61:407-414, 2002
38. Mikhailov MV, Mikhailova EA, Ashcroft SJH: Molecular structure of the glibenclamide binding site of the beta-cell K-ATP channel. FEBS Lett 499:154-160, 2001
39. Qian YM, Qiu W, Gao M, Westlake CJ, Cole SP, Deeley RG: Characterization of binding of leukotriene C4 by human multidrug resistance protein 1: Evidence of differential interactions with NH2- and COOH-proximal halves of the protein. J Biol Chem 276:38636-38644, 2001
40. Schwanstecher M, Schwanstecher C, Dickel C, Chudziak F, Moshiri A, Panten U: Location of the sulphonylurea receptor at the cytoplasmic face of the beta-cell membrane. Br J Pharmacol 113:903-1011, 1994
41. ATP channels. FEBS Lett 482:59-64, 2000
42. + channel in mouse pancreatic beta-cells. Pflügers Arch 407:493-499, 1986
43. ATP channels in mouse isolated pancreatic β-cells but not rat heart or arterial smooth muscle cells. Diabetologia 44:1019-1025, 2001
44. + channels from pancreatic β-cells. FEBS Lett 239:241-244, 1988
45. Schwanstecher C, Dickel C, Panten U: Cytosolic nucleotides enhance the tolbutamide sensitivity of the ATP-dependent K-channel in mouse pancreatic beta-cells by their combined actions at inhibitory and stimulatory sites. Mol Pharmacol 41:480-486, 1992
46. ATP channel by ATP. J Physiol 514:19-25, 1999
47. Schwanstecher M, Loser S, Rietze I, Panten U: Phosphate and thiophosphate group donating adenine and guanine nucleotides inhibit glibenclamide binding to membranes from pancreatic islets. Naunyn Schmiedebergs Arch Pharmacol 343:83-89, 1991
48. Ueda K, Komine J, Matsuo M, Seino S, Amachi T: Cooperative binding of ATP and MgADP in the sulphonylurea receptor is modulated by glibenclamide. Proc Natl Acad Sci U S A 96:1268-1272, 1999
49. + channel with an ABC transporter. Neuron 26:155-67, 2000
50. Chan KW, Logothetis DE: The first transmembrane domain of SUR1 enhances functional expression of Kir6.2 (Abstract). Biophys J 80:2820, 2001
51. Henquin JC, Garrino MG, Nenquin M: Stimulation of insulin release by benzoic acid derivatives related to the non-sulphonylurea moiety of glibenclamide: Structural requirements and cellular mechanisms. Eur J Pharmacol 141:243-251, 1987
52. Giblin JP, Leaney JL, Tinker A: The molecular assembly of ATP-sensitive potassium channels: Determinants of the pore forming subunit. J Biol Chem 274:22652-22659, 1999
53. Dabrowski M, Wahl P, Holmes WE, Ashcroft FM: Effect of repaglinide on cloned beta cell, cardiac and smooth muscle types of ATP-sensitive potassium channel. Diabetologia 44:747-756, 2001
54. Babenko AP, Gonzalez G, Aguilar-Bryan L, Bryan J: Reconstituted human cardiac KATP channels. Circ Res 83:1132-1143, 1998
55. Hansen AMK, Christensen IT, Hansen JB, Carr RD, Ashcroft FM, Wahl P: Differential actions of nateglinide and repaglinide on the human sulphonylurea receptor 1. Diabetes 51:2789-2795, 2002